Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Mindfulness Based Stress Reduction in Multiple Sclerosis (MS)

19. november 2014 oppdatert av: Lauren Krupp, Stony Brook University

Mindfulness Based Stress Reduction in MS

This study focuses on stress, cognition, mood and fatigue and its effect on medication compliance. Medication compliance is measured by the weight of discarded needles. The investigators will be administering neuropsychological testing at baseline and the final visit. The subjects will complete self-report assessments during their 8 weeks in the study.

Group A will have additional weekly phone support for meditation, while Group B will have meditation training only.

Studieoversikt

Status

Fullført

Forhold

Multippel sklerose

Intervensjon / Behandling

Atferdsmessig: Mindfulness based stress reduction (MBSR)

Studietype

Intervensjonell

Registrering (Faktiske)

Fase

Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

Forente stater
- New York
  - Stony Brook, New York, Forente stater, 11786-8121
    - Stony Brook University

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 70 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

Patients with either definite MS according to the revised McDonald criteria (Polman 2005) or patients with CIS (defined as an initial MS relapse with objective documentation and 2 or more lesions within the CNS of which at least one must involve the brain)
Patients on GA therapy for at least 6 months
Age 18 - 70

Exclusion Criteria:

Unwilling to comply with study procedures
Use of other DMT in conjunction with GA
Unable to provide informed consent.
Current (past 30 days) substance abuse
Newly initiated (past 30 days) psychiatry treatment
Enrolled in another program of meditation in the past six months.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Primært formål: Støttende omsorg
Tildeling: Randomisert
Intervensjonsmodell: Parallell tildeling
Masking: Enkelt

Hva måler studien?

Primære resultatmål

Resultatmål	Tiltaksbeskrivelse	Tidsramme
Electronic measure of needle disposals (MEMS TrackCaps) Tidsramme: Medication adherence will be measured by total number of missed doses, calculated from total needle disposals. The total number of missed doses across the six weeks will be compared between the two treatment groups at study end.	During the six-week MSBR program, medication adherence will be monitored with a widely used electronic measure of needle disposals (MEMS TrackCaps) This method has been demonstrated to be more accurate in MS than data obtained from either self-report or interview. At one month intervals the patient will bring the needle container to the Study Coordinator. All patients who attend at least introduction session and one telephone session will be included in the analysis.	Medication adherence will be measured by total number of missed doses, calculated from total needle disposals. The total number of missed doses across the six weeks will be compared between the two treatment groups at study end.

Sekundære resultatmål

Resultatmål	Tiltaksbeskrivelse	Tidsramme
Perceived Stress Scale-10 Tidsramme: Baseline, 1 X between weeks 3-7, Week 8	A 10-item scale of global perceived stress, where each item is rated from 1 to 5 according to intensity of stressor.	Baseline, 1 X between weeks 3-7, Week 8
Holmes and Rahe Social Readjustment Rating Scale (SRRS Tidsramme: Baseline, 1 X between weeks 3-7, Week 8	Stressful life events will be rated using the SRRS, which asks subjects to check if they have experienced any of a series of life events. We will use a modification of the scale used in previous MS research that eliminates several items specifically associated with MS disease activity (e.g., "major illness or injury", "sexual difficulties", "pregnancy"). The SRRS differentiates three types of stress: positive ("outstanding personal achievement"), major negative stress (death of family member), conflict and disruption in routine (e.g., family or job conflict, life changes).	Baseline, 1 X between weeks 3-7, Week 8
Chicago Multiscale Depression Inventory (CMDI) Tidsramme: Baseline, 1 X betweeen Weeks 3-7, Week 8	CMDI is a self-report questionnaire designed specifically for use in MS and other medical patient groups. It has vegetative, mood, and evaluative scales consisting of 14 items each. The use of the CMDI makes it possible to separate out neurovegetative symptoms of depression which are a potential confound in medical populations such as MS	Baseline, 1 X betweeen Weeks 3-7, Week 8
State Trait Anxiety Inventory (STAI) Tidsramme: Baseline, 1 X betweeen Weeks 3-7, Week 8	The STAI is a widely used measure of state and trait anxiety. We will focus on the measurement of state related anxiety in this study.	Baseline, 1 X betweeen Weeks 3-7, Week 8
Positive and Negative Affect Scale (PANAS) Tidsramme: Baseline, 1 X between Weeks 3 - 7, Week 8	; Watson, Clark & Tellegen, 1989): State related positive and negative affect will be assessed by the well validated PANAS scales.	Baseline, 1 X between Weeks 3 - 7, Week 8
Fatigue Severity Scale (FSS) Tidsramme: Baseline, 1 X between Weeks 3 - 7, Week 8	The fatigue severity scale is a reliable and valid commonly used measure of the frequent symptom of fatigue in MS.	Baseline, 1 X between Weeks 3 - 7, Week 8
MACFIMS neuropsychological battery Tidsramme: Baseline and Week 8	At baseline and study end, an abbreviated version of the MACFIMS will be administered. This is a standard neurocognitive battery used with studies of MS subjects and includes the SDMT, PASAT, SRT, BVMT, and 9-hole peg test.	Baseline and Week 8
Expanded Disability Status Scale (EDSS) Tidsramme: Baseline and Week 8	Expanded Disability Status Scale is the oldest and probably the most widely utilized assessment instruments in MS for determination of neurological impairment in MS. It is the standard for characterization of MS patients and for outcomes of clinical trials. It will be used to characterize patients' level of disability.	Baseline and Week 8
Physiologic Markers of Stress Tidsramme: Baseline and Week 8	DHEA, epinephrine, and norepinephrine.	Baseline and Week 8
Physiologic Maker of Stress Tidsramme: Baseline, 1 X between Week 3 - 7, Weeek 8	cortisol	Baseline, 1 X between Week 3 - 7, Weeek 8

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Sponsor

Stony Brook University

Samarbeidspartnere

Teva Pharmaceuticals USA

Etterforskere

Hovedetterforsker: Lauren B Krupp, M.D., Stony Brook University

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart

1. mai 2011

Primær fullføring (Faktiske)

1. april 2013

Studiet fullført (Faktiske)

1. november 2014

Datoer for studieregistrering

Først innsendt

5. november 2010

Først innsendt som oppfylte QC-kriteriene

16. august 2011

Først lagt ut (Anslag)

18. august 2011

Oppdateringer av studieposter

Sist oppdatering lagt ut (Anslag)

20. november 2014

Siste oppdatering sendt inn som oppfylte QC-kriteriene

19. november 2014

Sist bekreftet